These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 19545933)

  • 1. CALHM1 variant is not associated with Alzheimer's disease among Asians.
    Tan EK; Ho P; Cheng SY; Yih Y; Li HH; Fook-Chong S; Lee WL; Zhao Y
    Neurobiol Aging; 2011 Mar; 32(3):546.e11-2. PubMed ID: 19545933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic association between CALHM1, 2, and 3 polymorphisms and Alzheimer's disease in a Japanese population.
    Shibata N; Kuerban B; Komatsu M; Ohnuma T; Baba H; Arai H
    J Alzheimers Dis; 2010; 20(2):417-21. PubMed ID: 20164573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of implication for CALHM1 P86L common variation in Italian patients with early and late onset Alzheimer's disease.
    Nacmias B; Tedde A; Bagnoli S; Lucenteforte E; Cellini E; Piaceri I; Guarnieri BM; Bessi V; Bracco L; Sorbi S
    J Alzheimers Dis; 2010; 20(1):37-41. PubMed ID: 20164602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No association between CALHM1 polymorphism and Alzheimer's disease risk in a Hungarian population.
    Fehér A; Juhász A; Rimanóczy A; Pákáski M; Kálmán J; Janka Z
    Psychiatr Genet; 2011 Oct; 21(5):249-52. PubMed ID: 21378601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A polymorphism in CALHM1 is associated with temporal lobe epilepsy.
    Lv RJ; He JS; Fu YH; Shao XQ; Wu LW; Lu Q; Jin LR; Liu H
    Epilepsy Behav; 2011 Apr; 20(4):681-5. PubMed ID: 21439911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CALHM1 P86L polymorphism is associated with late-onset Alzheimer's disease in a recessive model.
    Boada M; Antúnez C; López-Arrieta J; Galán JJ; Morón FJ; Hernández I; Marín J; Martínez-Lage P; Alegret M; Carrasco JM; Moreno C; Real LM; González-Pérez A; Tárraga L; Ruiz A
    J Alzheimers Dis; 2010; 20(1):247-51. PubMed ID: 20164592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No association between CALHM1 and risk for Alzheimer dementia in a Belgian population.
    Sleegers K; Brouwers N; Bettens K; Engelborghs S; van Miegroet H; De Deyn PP; Van Broeckhoven C
    Hum Mutat; 2009 Apr; 30(4):E570-4. PubMed ID: 19191332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism of the regulatory region of the presenilin-2 gene in sporadic Alzheimer's disease: a case-control study.
    Quan W; Yasuda M; Hashimoto M; Yamamoto Y; Ishii K; Kazui H; Mori E; Kakigi T; Maeda K
    J Neurol Sci; 2006 Jan; 240(1-2):71-5. PubMed ID: 16233903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau haplotypes and ApoE4 do not act in synergy on Alzheimer's disease.
    Almos PZ; Horváth S; Czibula A; Raskó I; Domján N; Juhász A; Janka Z; Kálmán J
    Psychiatry Res; 2011 Apr; 186(2-3):448-50. PubMed ID: 20837363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association study and meta-analysis of Alzheimer's disease risk and presenilin-1 intronic polymorphism.
    Rodríguez-Manotas M; Amorín-Díaz M; Cañizares-Hernández F; Ruíz-Espejo F; Martínez-Vidal S; González-Sarmiento R; Martínez-Hernández P; Cabezas-Herrera J
    Brain Res; 2007 Sep; 1170():119-28. PubMed ID: 17719017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin converting enzyme insertion/deletion polymorphism in sporadic and familial Alzheimer's disease and longevity.
    Nacmias B; Bagnoli S; Tedde A; Cellini E; Bessi V; Guarnieri B; Ortensi L; Piacentini S; Bracco L; Sorbi S
    Arch Gerontol Geriatr; 2007; 45(2):201-6. PubMed ID: 17182125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenomodulin variants, APOE and Alzheimer's disease in a Finnish case-control cohort.
    Tolppanen AM; Helisalmi S; Hiltunen M; Kolehmainen M; Schwab U; Pirttilä T; Pulkkinen L; Uusitupa M; Soininen H
    Neurobiol Aging; 2011 Mar; 32(3):546.e7-9. PubMed ID: 19524323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The peroxisome proliferator-activated receptor gamma (PPAR-gamma2) Pro12Ala polymorphism is associated with higher risk for Alzheimer's disease in octogenarians.
    Scacchi R; Pinto A; Gambina G; Rosano A; Corbo RM
    Brain Res; 2007 Mar; 1139():1-5. PubMed ID: 17270153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic association of CTNNA3 with late-onset Alzheimer's disease in females.
    Miyashita A; Arai H; Asada T; Imagawa M; Matsubara E; Shoji M; Higuchi S; Urakami K; Kakita A; Takahashi H; Toyabe S; Akazawa K; Kanazawa I; Ihara Y; Kuwano R;
    Hum Mol Genet; 2007 Dec; 16(23):2854-69. PubMed ID: 17761686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland Chinese.
    Bian JT; Zhang JW; Zhang ZX; Zhao HL
    Neurosci Lett; 2005 Oct; 387(1):11-6. PubMed ID: 16054753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between the APOE epsilon4 allele and the APH-1b c + 651T > G SNP in Alzheimer's disease.
    Poli M; Gatta LB; Lovati C; Mariani C; Galimberti D; Scarpini E; Biunno I; Musicco M; Dominici R; Albertini A; Finazzi D
    Neurobiol Aging; 2008 Oct; 29(10):1494-501. PubMed ID: 17466415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CALHM1, a novel gene to blame in Alzheimer disease].
    Lambert JC; Campagne F; Marambaud P
    Med Sci (Paris); 2008 Nov; 24(11):923-4. PubMed ID: 19038093
    [No Abstract]   [Full Text] [Related]  

  • 18. -1154G/A and -2578C/A polymorphisms of the vascular endothelial growth factor gene in Tunisian Alzheimer patients in relation to beta-amyloid (1-42) and total tau protein.
    Smach MA; Charfeddine B; Othman LB; Lammouchi T; Ltaief A; Nafati S; Dridi H; Bennamou S; Limem K
    Neurosci Lett; 2010 Mar; 472(2):139-42. PubMed ID: 20138124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association study of the GAB2 gene with the risk of developing Alzheimer's disease.
    Chapuis J; Hannequin D; Pasquier F; Bentham P; Brice A; Leber I; Frebourg T; Deleuze JF; Cousin E; Thaker U; Amouyel P; Mann D; Lendon C; Campion D; Lambert JC
    Neurobiol Dis; 2008 Apr; 30(1):103-6. PubMed ID: 18272374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different implication of NEDD9 genetic variant in early and late-onset Alzheimer's disease.
    Tedde A; Bagnoli S; Piaceri I; Lucenteforte E; Bessi V; Bracco L; Mugelli A; Sorbi S; Nacmias B
    Neurosci Lett; 2010 Jun; 477(3):121-3. PubMed ID: 20430066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.